Log In
Wednesday 23rd May 2018

US body pledges AIDS money

21st April 2009

The United States has announced more than US$11 million in funding for HIV and tuberculosis-related programmes in Haiti, Uganda and China.


The Fogarty International Center of the National Institutes of Health said the money would be dispensed over a five-year period in grants.

It has also announced that it will establish a new programme in Tanzania.

The money is being awarded to researchers from the three countries, in the hope that it will further not only the treatment but also the prevention of HIV/AIDS and tuberculosis.

The two diseases often exist together in a given country, and the funding aims to train a range of healthcare professionals, including midwives, dentists, nurses, and healthcare administrators.

Almost three million individuals take antiretroviral HIV therapy, due in part to the international efforts of the World Health Organisation (WHO), the President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund for HIV, Tuberculosis and Malaria, the Clinton Foundation, and others.

Fogarty Director Roger Glass said that research had identified many effective ways to prevent HIV that had yet to be brought into routine practice.

He said, however, that many more people were still being infected than could be given treatment.

For every person on antiretroviral treatment, it is estimated that 2.5 million new HIV/AIDS infections take place.

Glass said that, if large investments in PEPFAR were to be effective, people would need to train a whole new generation of researchers to learn how to best implement HIV prevention programmes and how to make them work efficiently.

Muhimbili University of Health and Allied Sciences in Tanzania, in conjunction with the Harvard School of Public Health, would be among recepients of grant money to build up a health systems research programme.

Other organisations receiving money include The Chinese Center for Disease Control, in cooperatuon with with UCLA and Yale University, as well as the Haitian Study Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), in conjunction with the US-based Cornell University and Dartmouth College.

The awards are given out by the International Clinical, Operational, and Health Services Research and Training Awards for AIDS and Tuberculosis programme, currently also operating in Brazil, Peru, South Africa and Zimbabwe.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018